Synairgen plc (SYGGF)
Develops inhaled medicines to strengthen the lungs' natural defenses against viral infections.
$0.00+0.00%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago+0.0%
The outlook
SYGGF is trading near its 52-week low, though it sits above both its 50- and 200-day moving averages. Analyst coverage appears limited or unavailable for this micro-cap stock. The StockGlow score leans neutral, reflecting mixed or minimal data points.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range1% of the way from its 52-week low to high
Market cap
$110,266
52-wk high
$0.01
52-wk low
$0.00
50-day avg
$0.00
200-day avg
$0.00
Trailing P/E
—